drugset / Trial / NCT01474668

Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-0941 Following Single Oral Dose Administration in Healthy Male Subjects

NCT01474668

Phase 1 Completed 5 enrolled Genentech, Inc.
RandomizedSingle-groupOpen-labelTreatment

Summary

This study will be an open-label, non-randomized, absorption, metabolism, and excretion study of \[14C\]-GDC 0941 administered as an oral dose to 6 healthy male subjects following at least a 10-hour fast from food (not including water).

Timeline

Start
2011-10
Primary completion
2011-10
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Pictilisib Small molecule Oral

Indications

No indication recorded.